Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid
Title:
Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid
Author:
Kander, Elizabeth M. Shah, Manisha H. Zhou, Ye Goyal, Ashima Palmer, Joshua D. Owen, Dwight H. Shilo, Konstantin Patel, Gopal Raval, Raju R. Gonzalez, Javier Nguyen, Michele Olek, Elizabeth Kherani, Jennifer Rothenberg, S. Michael Konda, Bhavana